Trademark Overview
On Thursday, June 20, 2019, a trademark application was filed for INRETZIG with the United States Patent and Trademark Office. The USPTO has given the INRETZIG trademark a serial number of 88481458. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, July 30, 2019. This trademark is owned by Eli Lilly and Company. The INRETZIG trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcera...
